We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-2.92%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$1.93B
AUM Growth
-$130M
Cap. Flow
-$54.2M
Cap. Flow %
-2.81%
Top 10 Hldgs %
30.03%
Holding
2,489
New
31
Increased
1,105
Reduced
525
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Healthcare 11.48%
3 Financials 10.72%
4 Consumer Discretionary 9.28%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORC
1851
Orchid Island Capital
ORC
$1.32B
$21.9K ﹤0.01%
2,577
+540
+27% +$5.3K
BVH
1852
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$21.9K ﹤0.01%
596
AAN
1853
DELISTED
The Aaron's Company Inc
AAN
$21.8K ﹤0.01%
2,083
+473
+29% +$6.03K
DJCO icon
1854
Daily Journal
DJCO
$828M
$21.8K ﹤0.01%
74
ANAB icon
1855
AnaptysBio
ANAB
$1.66B
$21.8K ﹤0.01%
1,211
MVIS icon
1856
Microvision
MVIS
$89.7M
$21.7K ﹤0.01%
661
+62
+10% +$2.84K
STGW icon
1857
Stagwell
STGW
$2.28B
$21.7K ﹤0.01%
4,618
-1,311
-22% -$7.76K
JOUT icon
1858
Johnson Outdoors
JOUT
$512M
$21.5K ﹤0.01%
393
+121
+44% +$6.87K
CRBU icon
1859
Caribou Biosciences
CRBU
$160M
$21.5K ﹤0.01%
4,491
+1,213
+37% +$7.53K
NVEC icon
1860
NVE Corp
NVEC
$563M
$21.4K ﹤0.01%
261
UTMD icon
1861
Utah Medical Products
UTMD
$230M
$21.4K ﹤0.01%
249
+73
+41% +$6.74K
DYN icon
1862
Dyne Therapeutics
DYN
$4.85B
$21.3K ﹤0.01%
2,376
RMR icon
1863
The RMR Group
RMR
$346M
$21.3K ﹤0.01%
867
BALY icon
1864
Bally's
BALY
$660M
$21.3K ﹤0.01%
1,621
NRIX icon
1865
Nurix Therapeutics
NRIX
$2.82B
$21.2K ﹤0.01%
2,703
AGEN
1866
Agenus
AGEN
$315M
$21.2K ﹤0.01%
939
CCBG icon
1867
Capital City Bank Group
CCBG
$898M
$21.1K ﹤0.01%
708
NN icon
1868
NextNav
NN
$3.29B
$21.1K ﹤0.01%
4,108
CLFD icon
1869
Clearfield
CLFD
$390M
$21K ﹤0.01%
734
+76
+12% +$2.98K
PRME icon
1870
Prime Medicine
PRME
$575M
$21K ﹤0.01%
2,203
WALD icon
1871
Waldencast
WALD
$173M
$21K ﹤0.01%
2,230
+1,066
+92% +$7.57K
TWKS
1872
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$21K ﹤0.01%
5,141
SLGC
1873
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$20.9K ﹤0.01%
8,765
EQBK icon
1874
Equity Bancshares
EQBK
$1.07B
$20.9K ﹤0.01%
867
NWPX icon
1875
NWPX Infrastructure Inc
NWPX
$1.11B
$20.8K ﹤0.01%
691
+221
+47% +$6.95K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2023 Portfolio in Review

As of Q3 2023, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $1.93B, down 6.3% from $2.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.9%. Metropolitan Life Insurance Company (MetLife) opened 31 new positions and exited 91, leaving the 2,489-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2023 buy was Vanguard Long-Term Corporate Bond ETF: 296,480 shares worth $21.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q3 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $10.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited State Street SPDR Portfolio Long Term Corporate Bond ETF in Q3 2023, selling an estimated $23.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $1.93B portfolio in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 31 new positions and closed 91 in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 6.3% quarter-over-quarter to $1.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.